PCI Biotech Holding ASA (CHIX:PCIBO) Price-to-Tangible-Book : 1.53 (As of May. 22, 2024)

View and export this data going back to 2017. Start your Free Trial

What is PCI Biotech Holding ASA Price-to-Tangible-Book?

As of today (2024-05-22), PCI Biotech Holding ASA's share price is kr1.92. PCI Biotech Holding ASA's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was kr1.26. Hence, PCI Biotech Holding ASA's Price to Tangible Book Ratio of today is 1.53.

The historical rank and industry rank for PCI Biotech Holding ASA's Price-to-Tangible-Book or its related term are showing as below:

CHIX:PCIBo' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.33 Med: 5.03 Max: 25.14
Current: 1.55

During the past 13 years, PCI Biotech Holding ASA's highest Price to Tangible Book Ratio was 25.14. The lowest was 1.33. And the median was 5.03.

CHIX:PCIBo's Price-to-Tangible-Book is ranked better than
73.17% of 1230 companies
in the Biotechnology industry
Industry Median: 2.78 vs CHIX:PCIBo: 1.55

A closely related ratio is called PB Ratio. As of today, PCI Biotech Holding ASA's share price is kr1.92. PCI Biotech Holding ASA's Book Value per Sharefor the quarter that ended in Jun. 2023 was kr1.26. Hence, PCI Biotech Holding ASA's P/B Ratio of today is 1.53.

PCI Biotech Holding ASA Price-to-Tangible-Book Historical Data

The historical data trend for PCI Biotech Holding ASA's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Price-to-Tangible-Book Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

11.09

5.51

8.41

1.25

1.84

PCI Biotech Holding ASA Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.13	1.25	1.37	1.53	1.84

Competitive Comparison of PCI Biotech Holding ASA's Price-to-Tangible-Book

For the Biotechnology subindustry, PCI Biotech Holding ASA's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PCI Biotech Holding ASA's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Price-to-Tangible-Book falls into.

PCI Biotech Holding ASA Price-to-Tangible-Book Calculation

PCI Biotech Holding ASA's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	1.92	/	1.257
	=	1.53

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

PCI Biotech Holding ASA Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA (CHIX:PCIBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (CHIX:PCIBo) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PCIB:Norway 4QG:Germany

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (CHIX:PCIBO) Headlines

No Headlines